These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study. Hutchcraft ML; Zhang S; Lin N; Pickarski JC; Belcher EA; Wei S; Bocklage T; Miller RW; Villano JL; Cavnar MJ; Kim J; Arnold SM; Ueland FR; Kolesar JM JCO Precis Oncol; 2024 Jan; 8():e2300266. PubMed ID: 38295319 [TBL] [Abstract][Full Text] [Related]
5. Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients. Satake T; Kondo S; Tanabe N; Mizuno T; Katsuya Y; Sato J; Koyama T; Yoshida T; Hirata M; Yamamoto N Cancer Res Commun; 2023 Nov; 3(11):2302-2311. PubMed ID: 37916805 [TBL] [Abstract][Full Text] [Related]
6. Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer. Lincoln SE; Nussbaum RL; Kurian AW; Nielsen SM; Das K; Michalski S; Yang S; Ngo N; Blanco A; Esplin ED JAMA Netw Open; 2020 Oct; 3(10):e2019452. PubMed ID: 33026450 [TBL] [Abstract][Full Text] [Related]
7. Unexpected actionable genetic variants revealed by multigene panel testing of patients with uterine cancer. Heald B; Mokhtary S; Nielsen SM; Rojahn S; Yang S; Michalski ST; Esplin ED Gynecol Oncol; 2022 Aug; 166(2):344-350. PubMed ID: 35691755 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer. Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial. Shore N; Gazi M; Pieczonka C; Heron S; Modh R; Cahn D; Belkoff LH; Berger A; Mazzarella B; Veys J; Idom C; Morris D; Jayram G; Engelman A; Bukkapatnam R; Dato P; Bevan-Thomas R; Cornell R; Wise DR; Hardwick MK; Hernandez RD; Rojahn S; Layman P; Hatchell KE; Heald B; Nussbaum RL; Nielsen SM; Esplin ED Eur Urol Oncol; 2023 Oct; 6(5):477-483. PubMed ID: 37574391 [TBL] [Abstract][Full Text] [Related]
10. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing. Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424 [TBL] [Abstract][Full Text] [Related]
12. Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational study. Nacer DF; Vallon-Christersson J; Nordborg N; Ehrencrona H; Kvist A; Borg Å; Staaf J Genome Med; 2023 Apr; 15(1):25. PubMed ID: 37060015 [TBL] [Abstract][Full Text] [Related]